Enabling anti-tumor immunity by unleashing ILC2
نویسندگان
چکیده
منابع مشابه
Auto-immunity as Evolutionary by Product of Adoptive Immunity and Source of Anti-tumor Immunity Failure
One of the biggest threats to survival is infection, so that the immune system is under permanent and strong evolutionary pressure to be highly responsive. By tracing the evolution of the invertebrate LPPXQH V\VWHP LW FDQ EH VHHQ WKDW LW ODUJHO\ IROORZHG WKH 3FODVVLFDO ́ PRGHO EDVHG RQ EL-directional 3SUHGDWRU-SUH\ ́ UHODWLRQVKLSV 6LPLODUO\ WKH HYROXWLRQDU\ HPHUJHQFH RI 0+& V\VWHP DQG WKH PHFKDQL...
متن کاملImproved generation of anti-tumor immunity by antigen dose limitation
BACKGROUND The malignant cells of cutaneous T cell lymphoma (CTCL) display immunogenic peptides derived from the clonal T cell receptor (TCR) providing an attractive model for refinement of anti-tumor immunization methodology. To produce a clinically meaningful anti-tumor response, induction of cytotoxic anti-CTCL cells must be maximized while suppressive T regulatory cells (Treg) should be min...
متن کاملPharmacological Modulation of Anti-Tumor Immunity Induced by Oncolytic Viruses
Oncolytic viruses (OVs) not only kill cancer cells by direct lysis but also generate a significant anti-tumor immune response that allows for prolonged cancer control and in some cases cures. How to best stimulate this effect is a subject of intense investigation in the OV field. While pharmacological manipulation of the cellular innate anti-viral immune response has been shown by several group...
متن کاملRUNX3 methylation and anti-tumor immunity.
Altered DNA methylation is a hallmark of cancer genomes and has been advocated as both a marker and mechanism of the malignant phenotype. In the conventional view, such alterations include global DNA hypomethylation, linked to aberrant expression of oncogenic driver genes and more localised de novo hypermethylation at ‘CpG-island’ promoters, argued to cause inappropriate silencing of tumor supp...
متن کاملEngineering Anti-Tumor T Cell Immunity
T cell immunity is critical for protection against infectious agents as well as cancer. T cell immune response is a well orchestrated process that involves three key components. CD8+ T cells that harbor cytolytic machinery and can target and kill the tumor cells in an antigen specific manner, CD4+ T cells that can either “help” the generation of a productive CD8+ T cell or “regulate/suppress” i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell Research
سال: 2020
ISSN: 1001-0602,1748-7838
DOI: 10.1038/s41422-020-0330-9